Renaissance Capital logo

LENS News

US IPO Weekly Recap: Shake Shack and Spark spike over 100% in a week with 10 IPOs

SHAK

Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs this past week than any week in 2014, a year that had over 100 from the sector. With 14 IPOs to date, January 2015 fell...read more

Presbia prices IPO at $10, below the range

LENS

Presbia, which sells surgically implanted lenses to correct age-related vision loss, raised $42 million by offering 4.2 million shares at $10, below the $11 to $13 range. Presbia will list on the NASDAQ under the symbol LENS. Jefferies acted as sole bookrunner on the deal....read more

Week ahead: IPO market gains momentum with 12 deals including Shake Shack and health care

SHAK

Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the twelve deals are health care, as last year's most popular sector continues to outperform. Assuming they all price, there...read more

The eye IPO: Presbia sets terms for $50 million initial public offering

LENS

Presbia, which sells surgically implanted lenses to correct age-related vision loss, announced terms for its IPO on Thursday. The Dublin, Ireland-based company plans to raise $50 million by offering 4.2 million shares at a price range of $11 to $13. At the midpoint of the proposed range, it would command a market value of $160 million. Presbia targets the vision disorder...read more